Anakinra + Adalimumab Atto Interaction

Majorinteraction on record

Description

Increased risk of serious infection when combined with AMJEVITA. Concomitant use not recommended in RA patients.

Mechanism

TNF blocker combined with other biologic DMARD

Source: NLP:adalimumab-atto